Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Jul;76(1):143–148. doi: 10.1172/JCI111937

Human fibronectin metabolism.

B A Pussell, P W Peake, M A Brown, J A Charlesworth
PMCID: PMC423729  PMID: 4019773

Abstract

The metabolic behavior of fibronectin (Fn), a highly adhesive glycoprotein (440,000 mol wt), was studied in eight healthy control subjects and in 11 patients, six of whom were critically ill. Fn was purified from fresh human plasma, radiolabeled, and shown to retain function both in vitro and in vivo. Results showed that, in normal controls, Fn is a rapidly catabolized protein with a fractional catabolic rate (FCR) of 4.81%/h (range, 4.00-6.27), a half-life (t1/2) of 25 h (20-30), extravascular/intravascular diffusion ratio (EV/IV) of 2.04 (1.52-3.30), and a synthesis rate (SR) of 0.71 mg/kg body weight per h (0.61-0.87). There was evidence for extravascular catabolism in each subject. Plasma levels correlated with SR but not with t1/2 or FCR. Patients had a lower EV/IV ratio, and in two critically ill patients with low plasma Fn concentration the SR was markedly depressed. These findings suggest that reduced synthesis of Fn, rather than increased FCR or increased extravascular distribution, is responsible for Fn deficiency in critically ill patients.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boughton B. J., Simpson A., Chandler S. Functional hyposplenism during pneumococcal infection. Lancet. 1983 Jan 15;1(8316):121–122. doi: 10.1016/s0140-6736(83)91760-9. [DOI] [PubMed] [Google Scholar]
  2. Boughton B. J., Simpson A. Plasma fibronectin in acute leukaemia. Br J Haematol. 1982 Jul;51(3):487–491. doi: 10.1111/j.1365-2141.1982.tb02806.x. [DOI] [PubMed] [Google Scholar]
  3. Charlesworth J. A., Scott D. M., Pussell B. A., Peters D. K. Metabolism of human beta 1H: studies in man and experimental animals. Clin Exp Immunol. 1979 Dec;38(3):397–404. [PMC free article] [PubMed] [Google Scholar]
  4. Charlesworth J. A., Williams D. G., Sherington E., Lachmann P. J., Peters D. K. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest. 1974 Jun;53(6):1578–1587. doi: 10.1172/JCI107708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Charlesworth J. A., Williams D. G., Sherington E., Peters D. K. Metabolism of the third component of complement (C3) in normal human subjects. Clin Sci Mol Med. 1974 Feb;46(2):223–229. doi: 10.1042/cs0460223. [DOI] [PubMed] [Google Scholar]
  6. Deno D. C., Saba T. M., Lewis E. P. Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues. Am J Physiol. 1983 Oct;245(4):R564–R575. doi: 10.1152/ajpregu.1983.245.4.R564. [DOI] [PubMed] [Google Scholar]
  7. Heusser C., Boesman M., Nordin J. H., Isliker H. Effect of chemical and enzymatic radioiodination on in vitro human Clq activities. J Immunol. 1973 Mar;110(3):820–828. [PubMed] [Google Scholar]
  8. Kaplan J. E., Scovill W. A., Bernard H., Saba T. M., Gray V. Reticuloendothelial phagocytic response to bacterial challenge after traumatic shock. Circ Shock. 1977;4(1):1–12. [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Loegering D. J., Schneidkraut M. J. Effect of endotoxin on alpha 2 SB-opsonic protein activity and reticuloendothelial system phagocytic function. J Reticuloendothel Soc. 1979 Aug;26(2):197–204. [PubMed] [Google Scholar]
  11. MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
  12. Morell A., Terry W. D., Waldmann T. A. Metabolic properties of IgG subclasses in man. J Clin Invest. 1970 Apr;49(4):673–680. doi: 10.1172/JCI106279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mosher D. F., Williams E. M. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med. 1978 May;91(5):729–735. [PubMed] [Google Scholar]
  14. Nosslin B. Analysis of disappearance time-curves after single injection of labelled proteins. Ciba Found Symp. 1972;9:113–130. doi: 10.1002/9780470719923.ch7. [DOI] [PubMed] [Google Scholar]
  15. Reeve J., Pussell B., Gibbs G. P., Peters D. K. Interpretation of tracer studies on plasma protein turnover: comparison of methods and optimization of techniques. Clin Sci (Lond) 1982 Aug;63(2):175–185. doi: 10.1042/cs0630175. [DOI] [PubMed] [Google Scholar]
  16. Saba T. M., Blumenstock F. A., Weber P., Kaplan J. E. Physiologic role of cold-insoluble globulin in systemic host defense: implications of its characterization as the opsonic alpha 2-surface-binding glycoprotein. Ann N Y Acad Sci. 1978 Jun 20;312:43–55. doi: 10.1111/j.1749-6632.1978.tb16792.x. [DOI] [PubMed] [Google Scholar]
  17. Sherman L. A., Lee J. Fibronectin: blood turnover in normal animals and during intravascular coagulation. Blood. 1982 Sep;60(3):558–563. [PubMed] [Google Scholar]
  18. Sissons J. G., Liebowitch J., Amos N., Peters D. K. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation. J Clin Invest. 1977 Apr;59(4):704–715. doi: 10.1172/JCI108689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Waldmann T. A., Iio A., Ogawa M., McIntyre O. R., Strober W. The metabolism of IgE. Studies in normal individuals and in a patient with IgE myeloma. J Immunol. 1976 Oct;117(4):1139–1144. [PubMed] [Google Scholar]
  20. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  21. Yamada K. M., Olden K. Fibronectins--adhesive glycoproteins of cell surface and blood. Nature. 1978 Sep 21;275(5677):179–184. doi: 10.1038/275179a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES